EUCTR2004-003727-12-IT进行中（未招募）不适用
A single dose, randomized, 2-period crossover study in patients with hemophilia A to evaluate the pharmacokinetics of ReFactoO' [B-domain deleted recombinant human factor VIII (BDDrFVIII)] and AdvateO' [a full-length recombinant factor VIII (FLrFVIII)]
WYETH LEDERLE0 个研究点目标入组 30 人开始时间: 2012年1月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A Single Dose, Randomized, 2-Period Crossover Study in Patients with Hemophilia A to Evaluate the Pharmacokinetics of Refacto(B-domain deleted recombinant human factor VIII (BDDrFVIII) and Advate (a full-length recombinant factor VIII (FLrFVIII) - Refacto/Advate PK switchHemophilia AEUCTR2004-003727-12-GBWyeth Pharmaceuticals, Global Medical Affairs30
进行中（未招募）
不适用
A Single Dose, Randomized, 2-Period Crossover Study in Patients with Hemophilia A to Evaluate the Pharmacokinetics of Refacto(B-domain deleted recombinant human factor VIII (BDDrFVIII) and Advate (a full-length recombinant factor VIII (FLrFVIII) - Refacto/Advate PK switchHemophilia AEUCTR2004-003727-12-DEWyeth Pharmaceuticals, Global Medical Affairs30
进行中（未招募）
不适用
A SINGLE-DOSE, RANDOMIZED, TWO-PERIOD, CROSSOVER STUDY TO ASSESS BIOEQUIVALENCE BETWEEN TWO IBUPROFEN 200 MG TABLET FORMULATIONS, IN HEALTHY ADULTS.PainEUCTR2013-001442-34-SEMcNeil AB
尚未招募
1 期
Dr. Reddy’s is conducting comparative PK study with DRL_DA (Darbepoetein alfa), reference product (US registered Aranesp®) and reference medicinal product (EU registered Aranesp®) in healthy male volunteersCTRI/2023/09/057697Dr. Reddys Laboratories Ltd.
已完成
1 期
Comparative Study of 3 Tocilizumab Products in Normal Healthy VolunteeersCTRI/2022/01/039850Dr Reddys Laboratories Ltd127